top of page

Access consulting in the Nordics
— for therapies where experience makes a difference

We're a team of senior Nordic market access experts with a unique combination of health economic, medical, commercial and analytical capabilities.

The Macanda team has long backgrounds from the pharmaceutical industry, market access consulting, academia, and payer / HTA agencies in the Nordic countries. With a combined experience of more than 400 market access projects delivered, the team provides solutions to clients with complex market access demands in the biotech, pharmaceutical, and medtech industries.

Unique insights and experience from supporting innovations such as precision medicine, cell- and gene therapies (C&G), advanced therapeutic medicinal products (ATMP) and orphan drugs

High-quality access strategy development for market access in Sweden, Norway, Denmark and Finland

Expert knowledge in launch optimization, landscaping and opportunity assessment 

Analytical capabilities incl. health economic modelling, biostatistics and registry-based evidence generation

Experience across the full life-cycle of medical innovations and multiple therapeutical areas 

Senior consultants who can challenge and optimise your evidence generation and access plans

Logga med undertext.png
Early market access
  • Evidence generation plans
  • Landscaping & opportunity assessment
  • Launch strategy & readiness
Logga med undertext.png
Nordic reimbursement
  • Access strategy development
  • Reimbursement submission planning & development
  • Negotiation & contracting support
Logga med undertext.png
Evidence generation
  • Health economic analysis
  • Real-world evidence generation & analysis
  • Literature reviews
The Team

Join our team

Macanda is looking for an Analyst or Senior Analyst in market access and/or HEOR


We are looking for someone who has a proactive, solution-oriented approach, great analytic capability, and strong communication skills to support the provision of high quality, timely development, and on-time input to client projects. Assignments range in complexity from basic analysis and problem solving to assisting in the development of more complex solutions to leading small teams. Principal accountabilities include to carry out works relating to market access and HEOR to a high standard which meets or exceeds client expectations under supervision, independently and/or as part of a project team on defined tasks.

Macanda can offer an inspiring working environment focused on supporting access solutions for clients launching pharmaceuticals with complex access challenges, such as advanced therapies and orphan drugs, in the Nordic region. We are a senior team working closely together with the ambition to become the premier Market Access consultancy for the Nordics.

Your skills and experience:

  • Master’s degree in Life sciences/ Economics/ Biostatistics/ Mathematics/ Epidemiology/ Business Administration with strong record of academic achievement

  • Prior experience or proven interest in the healthcare and life science industries.

  • Excellent presentation, communication and client relationship building skills

  • Personable, realistic, willing, open, team-worker and flexible

  • Well organized and able to work on multiple tasks simultaneously

  • Enthusiastic to learn and motivated to develop

  • Fluent in English, written and verbally. Knowledge of Finnish is a plus.


Reach out to with your application or if you have any questions about the position/working at Macanda!



Get in touch!

Macanda AB

Stockholm, Sweden

+46 73 070 82 24

  • LinkedIn
Find us on Linkedin


Kick off Sandhamn.png

2 October, 2023

Macanda had a true Nordic kick-off experience in the archipelago, with sailing, sauna, crayfish, ice-cold swims and creative planning and goal-setting workshops! It feels great going into the fall with such a strong team!

Macanda kicks off the fall

18 September, 2023

Welcome August!

Welcome August to our team!

August brings two years of hands-on experience in Health Economics from Uppsala University where his achievement includes a master's thesis project, where he was entrusted by the Dental and Pharmaceutical Benefits Agency (TLV) to create a method for measuring public opinion in healthcare prioritization. This innovative method was later successfully put into practice in a national study conducted at Uppsala University, showcasing August's practical skills and contributions. August also earned the prestigious Uppsala Economics Association's scholarship, a testament to his exceptional aptitude for the subject.

We are excited to have August on board and we look forward to his valuable contributions to our client project! Welcome August!

Maria färg.JPG

29 August, 2023

We are overjoyed and honoured to welcome Maria Johansson to Macanda! In Sweden, Maria has held a range of senior positions with payers and HTA bodies for more than 20 years. Most recently she was Head of Unit and member of the management team of value-based pricing (VBP) at the Dental and Pharmaceutical Benefits Agency (TLV). Maria also has expertise from roles in the Expert groups and Drug-and-Therapeutic Committees in the Regions of Västerbotten and Jämtland.


We are eager to introduce Maria to our clients as she has joined as a Director and Senior Advisor in HTA and Clinical Value.

Welcome Maria!

24 April, 2023

We’d like to welcome our newest member of the team, Emin Ekström! 

Emin holds 10 years of experience in the field of health economics and is well-versed in many disciplines such as health economic modeling, systematic literature reviews and registry studies. In addition to serving as the designated economist on a committee at the Ministry of Health and Social Affairs (Socialdepartmentet), Emin has a history with Swedish HTA organizations, including the Dental and Pharmaceutical Benefits Agency (TLV) and the Swedish Agency for Health Technology Assessment (SBU). Emin has a MSc in Health Economics and Public Health from University of Gothenburg.

Welcome Emin!

10 February, 2023

We are excited to welcome Chantelle Murley to the growing Macanda team! Last year Chantelle defended her thesis in patient outcomes, sickness absence and socioeconomic consequences of multiple sclerosis at Karolinska Institutet and since then she has been working as a post-doctoral researcher. Before her academic career she had a placement in the policy team at Pharmac (New Zealand's HTA agency).

Welcome Chantelle!

21 December, 2022

Happy Holidays!

We wish our friends, clients and collaborators Happy Holidays and a safe, healthy, and prosperous New Year!


This year Macanda is supporting Doctors without Borders, MSF. Together, we contribute to life-saving health care — no matter who, where and why.

20 December, 2022

Macanda presents orphan drug market access landscape in Sweden

In anticipation of the upcoming change of presidency of the EU Council, Business Sweden organised a seminar in late November on patient access to rare disease treatments at the Swedish Embassy in Prague, Czech Republic, who holds the current presidency.


The purpose of the seminar, attended by health economists, decision makers, clinicians and patient organizations, was to exchange insights and ideas on the topic of Market Access and Health Economics of orphan drugs in Sweden and the Czech Republic.


Macanda’s Jonas Lindblom was invited to the seminar to present the orphan drug market access landscape in Sweden and the unique challenges that orphan drug companies and patients face in the value based Swedish setting. 


1 November, 2022

Macanda is strengthening the team with new partners!

Today Macanda is excited to welcome Marcus Hultberg, Jonas Lindblom and Emma Medin as new partners! Together we are establishing a Nordic market access consultancy for clients with therapies where experience makes a difference.

Emma, Jonas and Marcus hold extensive experience from consulting, medical, commercial, payer and academic roles, and from having supported clients in the Nordics with tailored market access solutions over the past decade. They have developed unique expertise in the field of access for advanced therapies (ATMPs) and orphan drugs in rare diseases and oncology. 

Welcome to the team!

22 August, 2022

Welcome Josefine!

There is nothing better in work life than to reunite with top talents that you have missed for their smartness and drive. Today is one of those better days, when we welcome our old colleague Josefine Röhss to Macanda!
Josefine sits on a rare competence of statistical skills joined with health-economic experience and has a background in both consultancy and pharma. She is quite the modeller and will help us set the stage for becoming the highest-quality Nordic market access consultancy and tackle the multiple challenges we face in taking new innovations to the market. Additional steps on this journey will be shared later in the fall.

25 March, 2022

Macanda is looking forward to seeing you at SHEA Gothenburg 2022!

Macanda will be attending the Swedish national health-economic conference organised by the Swedish Health Economics Association (SHEA) 6-7 April 2022. Hope to see you there!

Read more about the conference at SHEA's website.

17 March, 2022

Macanda is now a friend company of
Save the Children 2022

We are proud to contribute to the improvement of children’s lives around the world. The devastating war in Ukraine shows how important the humanitarian aid organisations are in enabling timely and effective emergency response, and the need for long-term commitment.

21 December, 2021

Licentiate thesis
successfully defended by Emma Söreskog

On December 21st, Macanda's Emma Söreskog successfully defended her Licentiate thesis "Spinal cord stimulation in chronic pain: a study of health outcomes and costs"at Karolinska Institutet.

Read an abstract of the thesis here. 

bottom of page